Loading...
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
BACKGROUND: Brain radiotherapy is used in the management of melanoma brain metastases (MBM) and can result in radionecrosis. Anti-PD-1 is active in the brain and may increase the risk of radionecrosis when combined with radiotherapy. We studied the incidence, associated factors and management of rad...
Na minha lista:
| Udgivet i: | Pigment Cell Melanoma Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258671/ https://ncbi.nlm.nih.gov/pubmed/30767428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12775 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|